The Impact Of Adjuvant Nephrectomy On Multimodality Treatment Of Metastatic Renal Cell Carcinoma
- 1 November 1994
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 152 (5 Part 1), 1399-1403
- https://doi.org/10.1016/s0022-5347(17)32430-8
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Cytoreductive surgery prior to interleukin-2-based therapy in patients with metastatic renal cell carcinomaUrology, 1993
- Regression of Metastatic Renal Cell Carcinoma After Cytoreductive NephrectomyJournal of Urology, 1993
- Interleukin-2 Immunotherapy Followed by Resection of Residual Renal Cell CarcinomaJournal of Urology, 1991
- Phase II Trial of High-Dose Intermittent Interleukin-2 in Metastatic Renal Cell Carcinoma: A Southwest Oncology Group StudyJNCI Journal of the National Cancer Institute, 1990
- Experience with the Use of High-Dose Interleukin-2 in the Treatment of 652 Cancer PatientsAnnals of Surgery, 1989
- Idiopathic Regression of Metastases from Renal Cell CarcinomaJournal of Urology, 1977
- The Role of Adjunctive Nephrectomy in Patients with Metastatic Renal Cell CarcinomaJournal of Urology, 1977
- Solitary Metastasis from Renal Cell CarcinomaJournal of Urology, 1975
- Renal Cell Carcinoma: Natural History and Chemotherapeutic ExperienceJournal of Urology, 1975
- Diagnosis and management of renal cell carcinomaA clinical and pathologic study of 309 casesCancer, 1971